文献速递外周动脉疾病

终末期肾病患者外周动脉疾病及多血管病变的结局

Outcomes of peripheral artery disease and polyvascular disease in patients with end-stage kidney disease.
PubMed 文献 · J Vasc Surg · 2024-01-19

基于美国肾脏数据系统,纳入透析起始6个月内的外周动脉疾病患者106,567例,按合并冠状动脉或脑血管病分为四组。中位随访546天,1年和3年主要不良肢体事件率分别为22.3%和35.0%;合并多血管病变与全因死亡、心肌梗死、卒中和主要不良肢体事件风险升高相关。

要点

  • 透析起始6个月内合并外周动脉疾病者1年主要不良肢体事件率为22.3%,3年为35.0%。
  • 合并冠状动脉和脑血管病与全因死亡风险升高相关(HR 1.28,95%CI 1.24-1.31)。
  • 每增加一个病变动脉床,长期结局呈递增式恶化。

核心结论

  • 终末期肾病患者外周动脉疾病负担高且长期结局差,每增加一个病变动脉床,结局呈递增式恶化。

研究设计与样本

  • 利用美国肾脏数据系统识别透析起始6个月内的外周动脉疾病患者,分为单纯外周动脉疾病、合并冠状动脉病、合并脑血管病、合并冠状动脉和脑血管病四组。
  • 共纳入106,567例患者,平均年龄71.2岁,女性占40.8%,中位随访546天(四分位距214-1096天)。

主要发现

  • 单纯外周动脉疾病占25.8%,合并冠状动脉病占49.8%,三个血管床均受累占19.2%。
  • 外周动脉疾病患者主要不良肢体事件率1年为22.3%,3年为35.0%。
  • 与单纯外周动脉疾病相比,合并冠状动脉和脑血管病与全因死亡风险升高相关(HR 1.28,95%CI 1.24-1.31)。
  • 与单纯外周动脉疾病相比,合并冠状动脉和脑血管病与心肌梗死风险升高相关(HR 1.78,95%CI 1.69-1.88)。
  • 与单纯外周动脉疾病相比,合并冠状动脉和脑血管病与卒中风险升高相关(HR 1.66,95%CI 1.52-1.80),与主要不良肢体事件风险升高相关(HR 1.07,95%CI 1.04-1.11)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Patients with peripheral artery disease (PAD) and end-stage kidney disease are a high-risk population, and concomitant atherosclerosis in coronary arteries (CAD) or cerebral arteries (CVD) is common. The aim of the study was to assess long-term outcomes of PAD and the impact of coexistent CAD and CVD on outcomes. METHODS: The United States Renal Data System was used to identify patients with PAD within 6 months of incident dialysis. Four groups were formed: PAD alone, PAD with CAD, PAD with CVD, and PAD with CAD and CVD. PAD-specific outcomes (chronic limb-threatening ischemia, major amputation, percutaneous/surgical revascularization, and their composite, defined as major adverse limb events [MALE]) as well as all-cause mortality, myocardial infarction, and stroke were studied. RESULTS: The study included 106,567 patients (mean age, 71.2 years; 40.8% female) with a median follow-up of 546 days (interquartile range, 214-1096 days). Most patients had PAD and CAD (49.8%), 25.8% had PAD alone, and 19.2% had all three territories involved. MALE rate in patients with PAD was 22.3% and 35.0% at 1 and 3 years, respectively. In comparison to PAD alone, the coexistence of both CAD and CVD (ie, polyvascular disease) was associated with a higher adjusted rates of all-cause mortality (hazard ratio [HR], 1.28; 95% confidence interval [CI], 1.24-1.31), myocardial infarction (HR, 1.78; 95% CI, 1.69-1.88), stroke (HR, 1.66; 95% CI, 1.52,1.80), and MALE (HR, 1.07; 95% CI, 1.04-1.11). CONCLUSIONS: Patients with end-stage kidney disease have a high burden of PAD with poor long-term outcomes, which worsen, in an incremental fashion, with the involvement of each additional diseased arterial bed.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Mehta H, Chan WC, Aday AW, et al. Outcomes of peripheral artery disease and polyvascular disease in patients with end-stage kidney disease. J Vasc Surg. 2024. PMID: 38244643. doi:10.1016/j.jvs.2024.01.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。